Skip to content

Envoy Medical COCH Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

AMB
Ambiq Micro, Inc.AMBQ
$3.01M
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$7.44M+743,800%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$5.44M
TRV
Trevi Therapeutics, Inc.TRVI
$2.54M
Dakota Gold logo
Dakota GoldDC
$10.9M+572%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's proceeds from warrant exercises?
Envoy Medical (COCH) reported proceeds from warrant exercises of $2.95M in Q4 2025.
What does proceeds from warrant exercises mean?
Cash inflows resulting from the exercise of outstanding warrants by holders to purchase common stock at a predetermined price. This activity provides capital to the company and reduces the potential future dilution associated with outstanding warrants. It is a key indicator of investor confidence and the company's ability to convert derivative liabilities into equity.